Cargando…

Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension

Shigella is the second most deadly diarrheal disease among children under five years of age, after rotavirus, with high morbidity and mortality in developing countries. Currently, no vaccine is widely available, and the increasing levels of multidrug resistance make Shigella a high priority for vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Micoli, Francesca, Rossi, Omar, Conti, Valentino, Launay, Odile, Sciré, Antonella Silvia, Aruta, Maria Grazia, Nakakana, Usman Nasir, Marchetti, Elisa, Rappuoli, Rino, Saul, Allan, Martin, Laura B., Necchi, Francesca, Podda, Audino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129577/ https://www.ncbi.nlm.nih.gov/pubmed/34017343 http://dx.doi.org/10.3389/fimmu.2021.671325

Ejemplares similares

Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study
por: Kapulu, Melissa C., et al.
Publicado: (2022)

Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA)
por: Mancini, Francesca, et al.
Publicado: (2021)

Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial
por: Launay, Odile, et al.
Publicado: (2019)

Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens
por: Gasperini, Gianmarco, et al.
Publicado: (2022)

Towards a Four-Component GMMA-Based Vaccine against Shigella
por: Micoli, Francesca, et al.
Publicado: (2022)

Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
por: Frenck, Robert W., et al.
Publicado: (2021)

Dissecting in Vitro the Activation of Human Immune Response Induced by Shigella sonnei GMMA
por: Tondi, Serena, et al.
Publicado: (2022)

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
por: De Ryck, Iris, et al.
Publicado: (2022)

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia
por: De Ryck, Iris, et al.
Publicado: (2022)

Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals
por: Di Benedetto, Roberta, et al.
Publicado: (2023)

Effect of O-Antigen Chain Length Regulation on the Immunogenicity of Shigella and Salmonella Generalized Modules for Membrane Antigens (GMMA)
por: Gasperini, Gianmarco, et al.
Publicado: (2021)

GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against Shigella flexneri Serotype 6
por: Raso, Maria Michelina, et al.
Publicado: (2020)

GMMA-Based Vaccines: The Known and The Unknown
por: Mancini, Francesca, et al.
Publicado: (2021)

Characterization of Competitive ELISA and Formulated Alhydrogel Competitive ELISA (FAcE) for Direct Quantification of Active Ingredients in GMMA-Based Vaccines
por: Rossi, Omar, et al.
Publicado: (2020)

A next-generation GMMA-based vaccine candidate to fight shigellosis
por: Rossi, Omar, et al.
Publicado: (2023)

Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component Shigella GMMA-Based Vaccines
por: Carson, Danielle, et al.
Publicado: (2021)

Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens
por: Di Benedetto, Roberta, et al.
Publicado: (2021)

Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
por: Gerke, Christiane, et al.
Publicado: (2015)

Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations
por: Maggiore, Luana, et al.
Publicado: (2016)

Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against Shigella
por: Rossi, Omar, et al.
Publicado: (2020)

Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella
por: Mancini, Francesca, et al.
Publicado: (2023)

Shigella sonnei
por: Torraca, Vincenzo, et al.
Publicado: (2020)

Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes
por: Citiulo, Francesco, et al.
Publicado: (2021)

Increasing the High Throughput of a Luminescence-Based Serum Bactericidal Assay (L-SBA)
por: Aruta, Maria Grazia, et al.
Publicado: (2021)

Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe
por: Launay, Odile, et al.
Publicado: (2017)

GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
por: Micoli, Francesca, et al.
Publicado: (2020)

Macrolide-Resistant Shigella sonnei
por: Boumghar-Bourtchai, Leyla, et al.
Publicado: (2008)

Neisseria meningitidis Factor H Binding Protein Surface Exposure on Salmonella Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both Diseases
por: Necchi, Francesca, et al.
Publicado: (2021)

THE SPECIFIC ANTIGENS OF VARIANTS OF SHIGELLA SONNEI
por: Baker, Edgar E., et al.
Publicado: (1949)

Global Distribution of Shigella sonnei Clones
por: Filliol-Toutain, Ingrid, et al.
Publicado: (2011)

Genome sequence of Shigella sonnei 4303
por: Deutsch-Nagy, Laura, et al.
Publicado: (2018)

Shigella sonnei: virulence and antibiotic resistance
por: Shad, Ahtesham Ahmad, et al.
Publicado: (2020)

A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
por: Obiero, Christina W., et al.
Publicado: (2017)

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022)

Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against Shigella flexneri
por: Mancini, Francesca, et al.
Publicado: (2022)

Investigating the Role of Antigen Orientation on the Immune Response Elicited by Neisseria meningitidis Factor H Binding Protein on GMMA
por: Alfini, Renzo, et al.
Publicado: (2022)

The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants
por: Thompson, Corinne N., et al.
Publicado: (2016)

Evolutionary histories and antimicrobial resistance in Shigella flexneri and Shigella sonnei in Southeast Asia
por: Chung The, Hao, et al.
Publicado: (2021)

Third-generation cephalosporin resistance in Shigella sonnei, Argentina.
por: Radice, M, et al.
Publicado: (2001)

Novel Extended-spectrum β-Lactamase in Shigella sonnei
por: Lefort, Agnes, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_gvlpt5ap4ohalje81fvgdokjnu